Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis - Divided Values

Type II network, divided values. Interestingly most of the proteins in the first 100 positions in this table would occur in the divided ranks table between position 100 and 200, indicating a difference in emphasis between the two simulations but not in the overall function. The fully annotated table, include Ensembl gene identifiers and network values can be found in the supplementary data.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 1 to 50 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
1\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rad50-interacting protein 1. [source:refseq;acc:nm\_021930]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
450.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
2394.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
5.31521\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rho-related btb domain-containing protein 2 (deleted in breast cancer 2 gene protein) (p83). [source:swissprot;acc:q9byz6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
3\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
homeobox protein hlx1 (homeobox protein hb24). [source:swissprot;acc:q14774]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
2597.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
698.5\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
3.71868\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
4\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hbs1-like. [source:refseq;acc:nm\_006620]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
5\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 3 (junctophilin type 3) (jp-3). [source:swissprot;acc:q8wxh2]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1153.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
339.5\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
3.39764\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
6\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
junctophilin 2 (junctophilin type 2) (jp-2). [source:swissprot;acc:q9br39]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
7\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
sphingomyelin phosphodiesterase 2 (ec 3.1.4.12) (neutral sphingomyelinase) (nsmase) (n-smase) (lyso-platelet activating factor- phospholipase c) (lyso-paf-plc). [source:swissprot;acc:o60906]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
8\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
db83 protein. [source:swissprot;acc:p57088]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
9\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tob2 protein (transducer of erbb-2 2). [source:swissprot;acc:q14106]\vspace{3pt}}&\multirow{6}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
398.5\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1281.5\vspace{3pt}}}&\multirow{6}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
3.21581\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
10\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
tob1 protein (transducer of erbb-2 1). [source:swissprot;acc:p50616]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
11\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dab2 interacting protein; ngap-like protein; doc-2/dab2 interactive protein. [source:refseq;acc:nm\_032552]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
12\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 4. [source:refseq;acc:nm\_030627]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
13\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytoplasmic polyadenylation element binding protein 3. [source:refseq;acc:nm\_014912]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
14\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ras gtpase-activating protein ngap (ras protein activator like 1). [source:swissprot;acc:q9ujf2]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
15\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
xpa binding protein 1; mbd2 interactor protein; putative atp(gtp)-binding protein. [source:refseq;acc:nm\_007266]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
2671\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
871\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
3.06659\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
16\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein x 0004. [source:refseq;acc:nm\_016301]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
17\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dgcr14 protein (digeorge syndrome critical region 14) (es2 protein). [source:swissprot;acc:q96df8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
460\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1365\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.96739\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
18\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14a; 17-kda pkc-potentiated inhibitory protein of pp1. [source:refseq;acc:nm\_033256]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
677.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1865.5\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.75351\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
19\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
microfibril-associated glycoprotein 4 precursor. [source:swissprot;acc:p55083]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
20\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory subunit 14d; pkc-dependent pp1 inhibitory protein. [source:refseq;acc:nm\_017726]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
21\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ficolin 2 precursor (collagen/fibrinogen domain-containing protein 2) (ficolin-b) (ficolin b) (serum lectin p35) (ebp-37) (hucolin) (l- ficolin). [source:swissprot;acc:q15485]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
22\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein phosphatase 1, regulatory (inhibitor) subunit 14c; serologically defined breast cancer antigen ny-br-81; pkc-potentiated pp1 inhibitory protein. [source:refseq;acc:nm\_030949]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
23\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
gbp protein isoform a. [source:refseq;acc:nm\_017870]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
699.76\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1894.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.7072\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
24\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
protein kinase, interferon-inducible double stranded rna dependent activator; protein activator of the interferon-induced protein kinase. [source:refseq;acc:nm\_003690]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
950.561\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2108.52\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.21818\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
25\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-7 subunit. [source:swissprot;acc:o60262]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1833.01\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
892.67\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.0534\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
26\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-12 subunit. [source:swissprot;acc:q9ubi6]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
27\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-4 subunit. [source:swissprot;acc:p50150]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.33\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.134\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04922\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
28\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-3 subunit. [source:swissprot;acc:p29798]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.36\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04912\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
29\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-8 subunit (gamma-9). [source:swissprot;acc:q9uk08]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.52\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.507\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04858\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
30\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 subunit. [source:swissprot;acc:p30670]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.59\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.633\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04837\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
31\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-10 subunit. [source:swissprot;acc:p50151]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.63\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.697\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
32\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-5 like subunit. [source:swissprot;acc:q9y3k8]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1834.73\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
895.893\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04793\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
33\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(o) gamma-11 subunit. [source:swissprot;acc:p50152]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1835.3\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
896.972\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.04611\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
34\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(y), alpha subunit (alpha-11). [source:swissprot;acc:p29992]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.71\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
907.546\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02382\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
35\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(q), alpha subunit. [source:swissprot;acc:p50148]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
907.564\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02378\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
36\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(z), alpha subunit (g(x) alpha chain) (gz-alpha). [source:swissprot;acc:p19086]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.76\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
907.741\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02344\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
37\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-1 subunit (transducin alpha-1 chain). [source:swissprot;acc:p11488]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
907.763\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02339\vspace{3pt}}\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
38\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(t), alpha-2 subunit (transducin alpha-2 chain). [source:swissprot;acc:p19087]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
907.774\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02337\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
39\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-2 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04899]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1836.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
907.903\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
2.02312\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
40\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i), alpha-1 subunit (adenylate cyclase-inhibiting g alpha protein). [source:swissprot;acc:p04898]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
1836.81\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
907.978\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
2.02297\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
41\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(k), alpha subunit (g(i) alpha-3). [source:swissprot;acc:p08754]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
42\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 5 (transducin beta chain 5). [source:swissprot;acc:o14775]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1857.32\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
958.237\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.93827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
43\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 3 (transducin beta chain 3). [source:swissprot;acc:p16520]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1881.02\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1027.36\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.83093\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
44\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein g(i)/g(s)/g(t) beta subunit 1 (transducin beta chain 1). [source:swissprot;acc:p04901]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1931.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1057.39\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.82652\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
45\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanine nucleotide-binding protein beta subunit 4 (transducin beta chain 4). [source:swissprot;acc:q9hav0]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1926.69\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1056.02\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.82448\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
46\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 2 (neurod2). [source:swissprot;acc:q15784]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
779.167\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
1390.33\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.78438\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
47\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
chromodomain helicase-dna-binding protein 3 (chd-3) (mi-2 autoantigen 240 kda protein) (mi2-alpha). [source:swissprot;acc:q12873]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
48\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
doc-1 related protein (doc-1r). [source:swissprot;acc:o75956]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
49\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 6 (neurod6) (my051 protein). [source:swissprot;acc:q96nk8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
50\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
neurogenic differentiation factor 1 (neurod1) (neurod). [source:swissprot;acc:q13562]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/